Origins of heterogeneous ovarian carcinomas: A molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components

American Journal of Pathology

Volumn 149, Issue 2, 1996, Pages 511-520

  Wolf, Nancy G ^a   Abdul Karim, Fadi W ^a   Schork, Nicholas J ^a   Schwartz, Stuart ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL;

ANEUPLOIDY; CHI-SQUARE DISTRIBUTION; CYTOGENETICS; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY, CONFOCAL; OVARIAN NEOPLASMS;

EID: 0030036738     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Boring CC, Squires TS, Tong T, Montgomery TS: Cancer statistics, 1994. CA Cancer J Clin 1994, 44:7-26
2. Serov SF, Scully RE, Sobin LH: Histological typing of ovarian tumours. International Histological Classification of Tumours, No. 9. Geneva, World Health Organization, 1973
3. Hart WR: Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential). Hum Pathol 1977, 8:541-549
4. Scully RE: Ovary. Pathology of Incipient Neoplasia, ed 2. Edited by DE Henson, J Albores-Saavedra. Philadelphia, WB Saunders, 1993, pp 283-300
5. Fearon ER, Vogelstein V: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
6. Puls LE, Powell DE, DePriest PD, Gallion HH, Hunter JE, Kryscio RJ, van Nagell JR Jr: Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol Oncol 1992, 47:53-57
7. Powell DE, Puls L, van Nagell J Jr: Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur? Hum Pathol 1992, 23:846-847
8. Scully RE: Letter to the editor: benign to malignant transformation in epithelial ovarian tumors. Hum Pathol 1993, 24:562-563
9. Zheng J, Wan M, Zweizig S, Velicescu M, Yu MC, Dubeau L: Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Cancer Res 1993, 53:4138-4142
10. Zheng J, Benedict WF, Xu H-J, Hu S-X, Kim TM, Velicescu M, Wan M, Cofer KF, Dubeau L: Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J Natl Cancer Inst 1995, 87:1146-1153
11. Yang-Feng TL, Li S-B, Leung W-Y, Carcangiu ML, Schwartz PE: Trisomy 12 and K-ras-2 amplification in human ovarian tumors, Int J Cancer 1991, 48:678-681
12. Pejovic T, Heim S, Mandahl N, Mitelman F: Trisomy 12 is a consistent chromosomal change in benign tumors of the ovary. Cancer Genet Cytogenet 1991, 52:230
13. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Flodérus U-M, Furgyik S, Helm G, Himmelmann A, Willén H, Mitelman F: Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes & Cancer 1992, 4:58-68
14. Thompson FH, Liu Y, Emerson J, Weinstein R, Makar R, Trent JM, Taetle R, Alberts DS: Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosomes & Cancer 1994, 10:262-266
15. Jenkins RB, Bartelt D Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L: Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 1993, 71:76-86
16. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB: Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 1993, 142:733-741
17. Persons DL, Hartmann LC, Keeney GL, Jenkins RB: Trisomy 12 detected by fluorescence in situ hybridization (FISH) in ovarian tumors. Am J Hum Genet 1993, 53(suppl):341A
18. Thompson FH, Emerson J, Alberts D,Liu Y, Guan X-Y, Burgess A, Fox S, Taetle R, Weinstein R, Maker R, Powell D, Trent J: Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 1994, 73:33-45
19. Schofield DE: Determination of aneuploidy using paraffin-embedded tissue. Current Protocols in Human Genetics. Edited by NC Dracopoli. JL Haines, BR Korf, DT Moir, CC Morton, CE Seidman, JG Seidman, DR Smith. John Wiley and Sons, 1995
20. Knoll JHM: In situ hybridization to metaphase chromosomes and interphase nuclei. Current Protocols in Human Genetics. Edited by NC Dracopoli, JL Haines, BR Korf, DT Moir, CC Morton, CE Seidman, JG Seidman, DR Smith. John Wiley and Sons, 1995
21. Liehr T, Stubinger A, Thoma K, Tulusan HA, Gebhart E: Comparative interphase cytogenetics using FISH on human ovarian carcinomas. Anticancer Res 1994, 14: 183-188
22. Zheng J, Robinson WR, Ehlen T, Yu MC, Dubeau L: Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification. Cancer Res 1991, 51:4045-4051
23. Wolman SR, Macoska JA, Micale MA, Sakr WA: An approach to definition of genetic alterations in prostate cancer. Diagn Mol Pathol 1992, 1:192-199
24. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE: Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 1994, 54:3824-3830
25. Micale MA, Visscher DW, Gulino SE, Wolman SR: Chromosomal aneuploidy in proliferative breast disease. Hum Pathol 1994, 25:29-35
26. Wolman SR: Fluorescence in situ hybridization: a new tool for the pathologist. Human Pathol 1994, 25:586-590
27. Plaxe SC, Deligdisch L, Dottino PR, Cohen CJ: Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma. Gynecol Oncol 1990, 38: 367-372